Why is Krebs Biochem falling/rising?

As of 18-Sep, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 78.16, which represents a decrease of Rs 2.84 or 3.51%. The stock has underperformed its sector by 4.56% today and has fallen after two consecutive days of gains. It opened with a loss of 3.89%, reaching an intraday low of Rs 77.85. Despite a significant increase in delivery volume, which rose by 594.17% against the 5-day average, the stock remains lower than the 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Year-to-date, the stock has declined by 15.50%, contrasting sharply with the Sensex's gain of 6.24% during the same period.
In the broader market context, Krebs Biochem's short-term performance over the past week shows a gain of 1.24%, which is less than the Sensex's increase of 1.80%. This underperformance highlights the stock's struggles relative to the broader market. Over the past year, Krebs Biochem has seen a decline of 16.05%, while the Sensex has remained relatively flat with a 0.08% increase. The liquidity of the stock is adequate for trading, but the overall negative sentiment and recent price movements suggest that investor confidence may be waning, contributing to the stock's current downward trajectory.